- Home
- Publications
- Publication Search
- Publication Details
Title
Development of Improved PPARβ/δ Inhibitors
Authors
Keywords
-
Journal
ChemMedChem
Volume 7, Issue 1, Pages 159-170
Publisher
Wiley
Online
2011-10-24
DOI
10.1002/cmdc.201100408
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A new, highly selective murine peroxisome proliferator-activated receptor δ agonist increases responsiveness to thermogenic stimuli and glucose uptake in skeletal muscle in obese mice
- (2011) R. A. Ngala et al. DIABETES OBESITY & METABOLISM
- A novel peroxisome proliferator-activated receptor delta antagonist, SR13904, has anti-proliferative activity in human cancer cells
- (2010) Nurulain T. Zaveri et al. CANCER BIOLOGY & THERAPY
- Therapeutic trials in nonalcoholic steatohepatitis: Insulin sensitizers and related methodological issues
- (2010) Vlad Ratziu et al. HEPATOLOGY
- Peroxisome proliferator-activated receptor δ agonists inhibit T helper type 1 (Th1) and Th17 responses in experimental allergic encephalomyelitis
- (2010) Saravanan Kanakasabai et al. IMMUNOLOGY
- Identification and Characterization of 4-Chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide (GSK3787), a Selective and Irreversible Peroxisome Proliferator-Activated Receptor δ (PPARδ) Antagonist
- (2010) Barry G. Shearer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cellular and Pharmacological Selectivity of the Peroxisome Proliferator-Activated Receptor- / Antagonist GSK3787
- (2010) P. S. Palkar et al. MOLECULAR PHARMACOLOGY
- Activation of PPARβ/δ Causes a Psoriasis-Like Skin Disease In Vivo
- (2010) Malgorzata Romanowska et al. PLoS One
- Sorting out the functional role(s) of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in cell proliferation and cancer
- (2009) Jeffrey M. Peters et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- 15-Hydroxyeicosatetraenoic Acid Is a Preferential Peroxisome Proliferator-Activated Receptor / Agonist
- (2009) S. Naruhn et al. MOLECULAR PHARMACOLOGY
- Ligand activation of peroxisome proliferator-activated receptor β/δ (PPARβ/δ) inhibits chemically induced skin tumorigenesis
- (2008) Moses T. Bility et al. CARCINOGENESIS
- Adipocyte-Derived Th2 Cytokines and Myeloid PPARδ Regulate Macrophage Polarization and Insulin Sensitivity
- (2008) Kihwa Kang et al. Cell Metabolism
- Alternative M2 Activation of Kupffer Cells by PPARδ Ameliorates Obesity-Induced Insulin Resistance
- (2008) Justin I. Odegaard et al. Cell Metabolism
- Ligand-Mediated Regulation of Peroxisome Proliferator-Activated Receptor (PPAR) / : A Comparative Analysis of PPAR-Selective Agonists and All-trans Retinoic Acid
- (2008) M. Rieck et al. MOLECULAR PHARMACOLOGY
- PPARδ Enhances Keratinocyte Proliferation in Psoriasis and Induces Heparin-Binding EGF-Like Growth Factor
- (2007) Malgorzata Romanowska et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Identification and Characterization of a Selective Peroxisome Proliferator-Activated Receptor β/δ (NR1C2) Antagonist
- (2007) Barry G. Shearer et al. MOLECULAR ENDOCRINOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now